Clinicopathological Relevance of SMAD4 and RUNX3 in Patients With Resected Pancreatic Cancer
Despite inherent limitations of this retrospective study and small sample size, our findings highlight the potential combined role of SMAD4 and RUNX3 in node metastasis and metastatic recurrence in patients with resected PDAC.
Authors
- Masakazu Yamamoto (ORCID: https://orcid.org/0000-0001-6027-620X)
- Toru Furukawa (ORCID: https://orcid.org/0000-0002-1083-2324)
- Katsuya Hirose (ORCID: https://orcid.org/0009-0003-6061-9219)
- Yuko Omori (ORCID: https://orcid.org/0009-0004-8285-5340)
- Ryota Higuchi
Institutions
- Center for Science in the Public Interest (United States) (US)
- U.S. National Science Foundation (US)
- Tohoku University (JP)
- Tokyo Women's Medical University (JP)
Publication Details
- Journal
- Pancreas
- Published
- 2024-11-13
- DOI
- https://doi.org/10.1097/mpa.0000000000002429
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.28